Tactile Medical Q3 net income $8.2M, revenue up 17%; raises FY guidance and authorizes $25M buyback

TACTILE SYSTEMS TECHNOLOGY INC

2025-Q3 EPS reported $0.36 revenue$225,928,000

Q3 revenue $85.8M (+17% YoY), net income $8.2M ($0.36 diluted EPS) vs $5.2M ($0.21) in Q3 2024.
Adjusted EBITDA $14.4M vs $10.7M YoY; gross margin 76% vs 75%.
Paid off $24M term loan, refinanced revolver to $40M; cash $66M.
Authorized $25M share buyback program through Nov 2027.
FY 2025 guidance raised: revenue $317-321M (prior $310-315M), adj. EBITDA $38-39.5M (prior $33-35M).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.